Navigation Links
Aspirus Heart & Vascular Institute Surgeon First in State to Implant Heart Device
Date:6/30/2010

AtriClip reduces stroke risk for a-fib patients.

Wausau, Wis. (PRWEB) June 30, 2010 -- Aspirus Heart & Vascular Institute cardiovascular surgeon John Johnkoski, M.D., on Friday, became the first physician in Wisconsin and one of only five in the nation to implant a heart device that greatly reduces the risk for stroke in patients with atrial fibrillation (a-fib).

A common heart condition that affects an estimated 2.5 million Americans, a-fib is an irregular heartbeat that is caused by a faulty electrical impulse. The abnormal heartbeat associated with a-fib can cause blood to pool in the left atrial appendage, a thumb-sized pouch on top of the heart where the majority of blood clots are thought to form.

The device implanted by Dr. Johnkoski, called the AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion device, clamps off blood flow to the appendage and prevents blood from pooling. By cutting off the blood flow, the chances of a clot forming in this high-risk area and causing a stroke are greatly reduced.

“Unless someone with a-fib undergoes a surgical procedure, the only way to reduce their risk of stroke is to take a blood-thinning medication like Coumadin,” Dr. Johnkoski said. “Coumadin can be difficult for some people to handle and it doesn’t mix well with an active lifestyle, but the AtriClip implant can allow a person to get off it, which is a huge benefit.”

The AtriClip blocks blood flow to the appendage more effectively than other techniques and is designed to be implanted from the outside of the heart, avoiding contact with circulating blood.

“The AtriClip is more effective than a stapling method in completely closing off the area of the heart where blood can pool,” Dr. Johnkoski said. “Blocking off blood flow with this device prevents the formation of pockets or pouches where clots can develop and lowers the incidence of stroke in patients with a-fib.”

In addition to implanting the AtriClip device, Dr. Johnkoski also performs an advanced surgical procedure for a-fib called thoracoscopic ablation, or mini-maze. This procedure is a minimally-invasive technique that is performed through a few small incisions on a patient’s side.

Dr. Johnkoski has performed more than 160 surgical ablations and is a recognized leader in the field, as the Aspirus Heart & Vascular Institute is one of fewer than 50 centers in the country to offer the procedure.

For more information about a-fib and treatments for the condition, visit www.treatafib.org.

Contact: Greg Aune, 715.847.0479

# # #

Read the full story at http://www.prweb.com/releases/2010/06/prweb4206884.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aspirus Eases Pain of Rapid Data Growth With an EMC Information Infrastructure
2. New research identifies modifiable risk factors for heart disease
3. Magnetic field measurements of the human heart at room temperature
4. Summit Medical Group hosts “Go Red Day” to Raise Awareness of Heart Disease and Stroke
5. Top 10 Ways to Avoid a Heart Attack This Super Bowl
6. Blood Thinner Combos Risky for Heart Attack Patients
7. HeartMath Offers Free Certificates that Celebrate Love and the Heart
8. Texas Health Dallas Launches Screening Program for Female Heart Disease
9. NHLBI funds preclinical tests on devices for infants and children with congenital heart defects
10. Surgery on beating heart thanks to robotic helping hand
11. Renowned Cardiologist Offers Heart Healthy Tips for the Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirus Heart & Vascular Institute Surgeon First in State to Implant Heart Device
(Date:3/28/2017)... Wallingford, CT (PRWEB) , ... March 28, 2017 ... ... hemostatic devices, announces today that the University of Pittsburgh Medical Center (UPMC) will ... Central and Western Pennsylvania. , The program, developed in association with efforts by ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Usually, the ... the daily wardrobe. However, for those self-conscious about a double chin, this means more ... the ideal solution. , “For most people, a double chin is undesirable,” Dr. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, ... to ensuring high-quality results and maintaining GMP and USP compliance. In a new ... accordance with GMP requirements " these requirements are explained. The challenge is ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the United ... can be limited while the desire to conquer breakouts and eliminate skincare stress is ... every customer online, today released its inaugural survey on the State of Acne in ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LightIntegra Technology Inc. today announced that its ... President and Chief Executive Officer effective March 13, 2017. ... Directors of LightIntegra. Paul Geyer will continue ... "This is the perfect time for Bill ... We,ve selected a very strong leader at a time ...
(Date:3/27/2017)... 2017  Sanderling Ventures, portfolio company, Torax Medical, ... of Johnson & Johnson. Torax manufactures and markets the ... gastro-esophageal reflux disease (GERD). The LINK device is ... the procedure is currently available in the U.S. ... was founded by Sanderling Ventures, Mayo Medical Ventures ...
(Date:3/27/2017)... March 27, 2017 FinancialBuzz.com News Commentary  ... Based on New Frontier ... states where cannabis is legal will generate $655 million in taxes ... from cannabis specific taxes, such as Washington State,s ... be earned from state sales taxes that are applied on all ...
Breaking Medicine Technology: